LG AI Research Signs Master Agreement With D&D Pharmatech For Oral Peptide Drug Development
LG AI Research just inked a deal with D&D Pharmatech to work on oral peptide development. That’s a big move. Peptides are usually injected or delivered in ways that dodge the digestive system. Oral delivery has always been the holy grail for peptide researchers—better compliance, simpler protocols, and massive commercial upside.
TradingView
“LG AI Research Signs Master Agreement With D&D Pharmatech For Oral Peptide Drug Development TradingView”
Here’s what stands out: LG AI Research brings artificial intelligence muscle. D&D Pharmatech brings biotech know-how. Together, they’re targeting a problem that’s stumped pharma giants for years: how to keep peptides intact through the stomach, get them absorbed, and actually deliver results. If their AI tools can crack the code, it’ll be a game-changer for the peptide field.
Why this matters for the research community:
Oral peptides mean easier administration, which could speed up experimentation and open new research models.
More vendors may start offering oral peptide formats if tech improves, expanding sourcing options. Check the vendor directory to see who’s getting involved.
AI-guided design could cut development times and costs for novel peptides, accelerating the entire peptide research index.
Key takeaway: The oral peptide pipeline is finally getting serious attention from major players. If LG and D&D’s approach works, expect a wave of new oral peptide compounds hitting the research market.
Bottom line: Keep an eye on this partnership. Oral peptide breakthroughs always start in the lab, and this is where the next wave could come from.
Related Reading
Saitama University researchers discover that a natural peptide aptamer switches between two target proteins depending on metal ions
News · EIN PresswirePeptide Therapeutics Market Revenue To Cross $222 Billion By 2030 Supported By Rising Demand
News · The Globe and MailPepMD Launches to Establish Credentialing and Trust Standards for Peptide Medicine
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.